等待开盘 08-10 09:30:00 美东时间
-0.200
-3.60%
Beyond Air (NASDAQ:XAIR) sees Calendar Year 2027 sales of $16.000 million-$18.000 million
06-26 19:21
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.57) by 35.09 percent. This is a 57.22 percent increase over losses of $(1.80) per share from the
06-26 19:11
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 du...
04-13 20:05
Beyond Air (NASDAQ:XAIR) affirms FY2026 sales outlook from $8.000 million-$10.000 million to $8.000 million-$10.000 million.
02-13 20:44
Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and milestones, as XAIR stock jumps 165% premarket.
01-14 02:40
Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients,
2025-12-17 20:36
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
中新网深圳10月11日电 (索有为 杨佳林 张炜童)广东省卓越人工智能与机器人奖(XAIR奖)启动仪式10日在深圳举行,2025XAIR奖将评选出人工智能与机器...
2025-10-11 13:56
Beyond Air submitted a PMA supplement for LungFit PH II, a smaller, lighter, transport-ready nitric oxide generator designed for improved respiratory treatments, offering enhanced portability and safety compared to legacy systems.
2025-06-16 12:00
北京时间2025年02月05日03时16分,阿尔法泰克(ATEC.us)股票出现波动,股价大幅拉升5.02%。截至发稿,该股报12.04美元/股,成交量56.4215万股,换手率0.40%,振幅5.85%。 最近的财报数据显示,该股实现营业收入1.51亿美元,净利润-39.62百万美元,每股收益-0.28美元,毛利82.08百万美元,市盈率-9.54倍。 机构评级方面,在所有12家参与评级的机构中,92%的券商给予买入建议,8%的券商给予持有建议,无券商给予卖出建议。 阿尔法泰克股票所在的医疗器械行业中,整体涨幅为0.10%。其相关个股中,Butterfly Network, Inc.、Pav...
2025-02-05 03:16